DelveInsight's B-cell Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable ...

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

Investors and the general public are invited to listen to a live webcast of the presentation through the "Investors" section ...

This mysterious autoimmune disease presents with over 100 different symptoms, making diagnosis incredibly challenging for ...

Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

A non-profit that supports lupus patients across the state is now asking Michiganders for some financial help. Members of the Michigan Lupus Foundation say they’re dealing ...

It started with a fever, then every part of my body was swelling – my hands, face, feet. It was very distressing. I would ...

Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.

A community came together Sunday afternoon to strike out Lupus with their 5th annual bowling fundraiser. (WLNS)(WLNS) Bowling, a sport Chris Hall loves to do whenever ...

Approximately 1 in 10 patients with lupus nephritis eventually progresses to kidney failure. Longer remission may help prevent chronic kidney disease (CKD) onset.

Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy Targeting Lupus Nephritis, Systemic Lupus Erythematosus and Multiple Sclerosis < ...